Determinants of endothelial function in patients with COPD

European Respiratory Journal

Volumn 42, Issue 5, 2013, Pages 1194-1204

  Clarenbach, Christian F ^a   Senn, Oliver ^b   Sievi, Noriane A ^a   Camen, Giovanni ^a   Van Gestel, Arnoldus J R ^a   Rossi, Valentina A ^a   Puhan, Milo A ^c   Thurnheer, Robert ^d   Russi, Erich W ^a,b   Kohler, Malcolm ^a,b  

^a UNIVERSITY HOSPITAL ZURICH   (Switzerland)

^b UNIVERSITY OF ZURICH   (Switzerland)

^c JOHNS HOPKINS BLOOMBERG SCHOOL OF PUBLIC HEALTH   (United States)

^d Kantonsspital Muensterlingen   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

BETA ADRENERGIC RECEPTOR BLOCKING AGENT; C REACTIVE PROTEIN; INTERLEUKIN 6; LONG ACTING DRUG; MALONALDEHYDE; STEROID;

ADULT; AGE; AGED; AIRWAY OBSTRUCTION; ARTERIAL CARBON DIOXIDE TENSION; ARTICLE; BLOOD GAS ANALYSIS; BLOOD PRESSURE MEASUREMENT; BRACHIAL ARTERY; CARDIOVASCULAR DISEASE; CARDIOVASCULAR RISK; CHRONIC OBSTRUCTIVE LUNG DISEASE; CONTROLLED STUDY; CROSS-SECTIONAL STUDY; DILATATION; DISEASE SEVERITY; ELECTROCARDIOGRAM; ENDOTHELIAL DYSFUNCTION; EXERCISE; FEMALE; FLOW MEDIATED DILATATION; FORCED EXPIRATORY VOLUME; HEART RATE; HUMAN; HYPERCAPNIA; HYPOXEMIA; LUNG ALVEOLUS OXYGEN TENSION; LUNG ENDOTHELIUM; LUNG FUNCTION; MAJOR CLINICAL STUDY; MALE; OXIDATIVE STRESS; PHYSICAL ACTIVITY; PRESSORECEPTOR REFLEX; PRIORITY JOURNAL; SMOKING; SUPINE POSITION; SYMPATHETIC FUNCTION; SYSTEMIC INFLAMMATORY RESPONSE SYNDROME; WALKING SPEED;

ADRENAL CORTEX HORMONES; ADULT; AGED; ANOXIA; BAROREFLEX; BLOOD GAS ANALYSIS; BLOOD PRESSURE; BRACHIAL ARTERY; C-REACTIVE PROTEIN; CARDIOVASCULAR DISEASES; COHORT STUDIES; ENDOTHELIUM, VASCULAR; FEMALE; FORCED EXPIRATORY VOLUME; HEART RATE; HUMANS; INFLAMMATION; MALE; MIDDLE AGED; OXIDATIVE STRESS; OXYGEN; PULMONARY DISEASE, CHRONIC OBSTRUCTIVE; REGRESSION ANALYSIS; RISK; SYMPATHETIC NERVOUS SYSTEM;

EID: 84880252442     PISSN: 09031936     EISSN: 13993003     Source Type: Journal    
DOI: 10.1183/09031936.00144612     Document Type: Article

References (37)

1. McGarvey LP, John M, Anderson JA, et al. Ascertainment of cause-specific mortality in COPD: operations of the TORCH Clinical Endpoint Committee. Thorax 2007; 62: 411-415.
2. Engström G, Melander O, Hedblad B. Population-based study of lung function and incidence of heart failure hospitalisations. Thorax 2010; 65: 633-638.
3. Sin DD, Wu L, Man SF. The relationship between reduced lung function and cardiovascular mortality: A population-based study and a systematic review of the literature. Chest 2005; 127: 1952-1959.
4. Curkendall SM, DeLuise C, Jones JK, et al. Cardiovascular disease in patients with chronic obstructive pulmonary disease, Saskatchewan Canada: cardiovascular disease in COPD patients. Ann Epidemiol 2006; 16: 63-70.
5. Sabit R, Thomas P, Shale DJ, et al. The effects of hypoxia on markers of coagulation and systemic inflammation in patients with COPD. Chest 2010; 138: 47-51.
6. Sin DD, Man SF. Chronic obstructive pulmonary disease: A novel risk factor for cardiovascular disease. Can J Physiol Pharmacol 2005; 83: 8-13.
7. MacNee W. Pulmonary and systemic oxidant/antioxidant imbalance in chronic obstructive pulmonary disease. Proc Am Thorac Soc 2005; 2: 50-60.
8. Watz H, Waschki B, Boehme C, et al. Extrapulmonary effects of chronic obstructive pulmonary disease on physical activity: A cross-sectional study. Am J Respir Crit Care Med 2008; 177: 743-751.
9. Garcia-Aymerich J, Lange P, Benet M, et al. Regular physical activity reduces hospital admission and mortality in chronic obstructive pulmonary disease: A population based cohort study. Thorax 2006; 61: 772-778.
10. Waschki B, Kirsten A, Holz O, et al. Physical activity is the strongest predictor of all-cause mortality in patients with COPD: A prospective cohort study. Chest 2011; 140: 331-342.
11. Pitta F, Troosters T, Probst VS, et al. Physical activity and hospitalization for exacerbation of COPD. Chest 2006; 129: 536-544.
12. Rubinshtein R, Kuvin JT, Soffler M, et al. Assessment of endothelial function by non-invasive peripheral arterial tonometry predicts late cardiovascular adverse events. Eur Heart J 2010; 31: 1142-1148.
13. Lind L, Berglund L, Larsson A, et al. Endothelial function in resistance and conduit arteries and 5-year risk of cardiovascular disease. Circulation 2011; 123: 1545-1551.
14. Celermajer DS, Sorensen KE, Gooch VM, et al. Non-invasive detection of endothelial dysfunction in children and adults at risk of atherosclerosis. Lancet 1992; 340: 1111-1115.
15. Gokce N, Keaney JF Jr, Hunter LM, et al. Risk stratification for postoperative cardiovascular events via noninvasive assessment of endothelial function: A prospective study. Circulation 2002; 105: 1567-1572.
16. Rabe KF, Hurd S, Anzueto A, et al. Global strategy for the diagnosis, management, and prevention of chronic obstructive pulmonary disease: GOLD executive summary. Am J Respir Crit Care Med 2007; 176: 532-555.
17. Westerhof BE, Gisolf J, Stok WJ, et al. Time-domain cross-correlation baroreflex sensitivity: performance on the EUROBAVAR data set. J Hypertens 2004; 22: 1371-1380.
18. Pocock SJ, McCormack V, Gueyffier F, et al. A score for predicting risk of death from cardiovascular disease in adults with raised blood pressure, based on individual patient data from randomised controlled trials. BMJ 2001; 323: 75-81.
19. Waschki B, Spruit MA, Watz H, et al. Physical activity monitoring in COPD: compliance and associations with clinical characteristics in a multicenter study. Respir Med 2012; 106: 522-530.
20. Watz H, Waschki B, Meyer T, et al. Physical activity in patients with COPD. Eur Respir J 2009; 33: 262-272.
21. Van Remoortel H, Raste Y, Louvaris Z, et al. Validity of six activity monitors in chronic obstructive pulmonary disease: A comparison with indirect calorimetry. PLoS One 2012; 7: e39198.
22. Brooks D, Solway S, Gibbons WJ. ATS statement on six-minute walk test. Am J Respir Crit Care Med 2003; 167: 1287.
23. Clarenbach CF, Thurnheer R, Kohler M. Vascular dysfunction in chronic obstructive pulmonary disease: current evidence and perspectives. Expert Rev Respir Med 2012; 6: 37-43.
24. Barr RG, Mesia-Vela S, Austin JH, et al. Impaired flow-mediated dilation is associated with low pulmonary function and emphysema in ex-smokers: The Emphysema and Cancer Action Project (EMCAP) Study. Am J Respir Crit Care Med 2007; 176: 1200-1207.
25. Eickhoff P, Valipour A, Kiss D, et al. Determinants of systemic vascular function in patients with stable chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2008; 178: 1211-1218.
26. Thijssen DH, Black MA, Pyke KE, et al. Assessment of flow-mediated dilation in humans: A methodological and physiological guideline. Am J Physiol Heart Circ Physiol 2011; 300: H2-H12.
27. Maclay JD, McAllister DA, Mills NL, et al. Vascular dysfunction in chronic obstructive pulmonary disease. Am J Respir Crit Care Med 2009; 180: 513-520.
28. Magnussen H, Watz H. Systemic inflammation in chronic obstructive pulmonary disease and asthma: relation with comorbidities. Proc Am Thorac Soc 2009; 6: 648-651.
29. Rahman I. The role of oxidative stress in the pathogenesis of COPD: implications for therapy. Treat Respir Med 2005; 4: 175-200.
30. Del Rio D, Stewart AJ, Pellegrini N. A review of recent studies on malondialdehyde as toxic molecule and biological marker of oxidative stress. Nutr Metab Cardiovasc Dis 2005; 15: 316-328.
31. Heindl S, Lehnert M, Criée CP, et al. Marked sympathetic activation in patients with chronic respiratory failure. Am J Respir Crit Care Med 2001; 164: 597-601.
32. Scalvini S, Porta R, Zanelli E, et al. Effects of oxygen on autonomic nervous system dysfunction in patients with chronic obstructive pulmonary disease. Eur Respir J 1999; 13: 119-124.
33. Haider T, Casucci G, Linser T, et al. Interval hypoxic training improves autonomic cardiovascular and respiratory control in patients with mild chronic obstructive pulmonary disease. J Hypertens 2009; 27: 1648-1654.
34. Pialoux V, Hanly PJ, Foster GE, et al. Effects of exposure to intermittent hypoxia on oxidative stress and acute hypoxic ventilatory response in humans. Am J Respir Crit Care Med 2009; 180: 1002-1009.
35. Foster GE, Brugniaux JV, Pialoux V, et al. Cardiovascular and cerebrovascular responses to acute hypoxia following exposure to intermittent hypoxia in healthy humans. J Physiol 2009; 587: 3287-3299.
36. Hambrecht R, Adams V, Erbs S, et al. Regular physical activity improves endothelial function in patients with coronary artery disease by increasing phosphorylation of endothelial nitric oxide synthase. Circulation 2003; 107: 3152-3158.
37. Kojda G, Cheng YC, Burchfield J, et al. Dysfunctional regulation of endothelial nitric oxide synthase (eNOS) expression in response to exercise in mice lacking one eNOS gene. Circulation 2001; 103: 2839-2844.